Vir Biotechnology, Inc. — Director's Dealing 2019

Oct 11, 2019

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Vir Biotechnology, Inc. (VIR)
CIK: 0001706431
Period of Report: 2019-10-10

Reporting Person: Virgin Herbert (EVP, Research & CSO)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$1.53	2028-01-26	Common Stock (555555)		Direct
Stock Option (Right to Buy)	$10.40	2029-07-12	Common Stock (133332)		Direct

Footnotes

F1: 1/4 of the shares subject to the stock option vested and became exercisable on January 8, 2019, and the remaining shares vest in 36 equal monthly installments thereafter.

F2: 1/4 of the shares subject to the stock option will vest and become exercisable on July 12, 2020, and the remaining shares will vest in 36 equal monthly installments thereafter.